Your browser doesn't support javascript.
loading
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.
Abudayyeh, Ala; Lin, Heather; Abdelrahim, Maen; Rondon, Gabriela; Andersson, Borje S; Martinez, Charles S; Page, Valda D; Tarrand, Jeffrey J; Kontoyiannis, Dimitrios P; Marin, David; Oran, Betul; Olson, Amanda; Jones, Roy; Popat, Uday; Champlin, Richard E; Chemaly, Roy F; Shpall, Elizabeth J; Rezvani, Katayoun.
Afiliação
  • Abudayyeh A; Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Abdelrahim M; Institute of Academic Medicine and Weill Cornell Medical College, Houston Methodist Cancer Center, Houston, TX, USA.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Andersson BS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martinez CS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Page VD; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tarrand JJ; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kontoyiannis DP; Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marin D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Oran B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Olson A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jones R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chemaly RF; Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Transpl Infect Dis ; 22(5): e13395, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32602954
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Tumorais por Vírus / Transplante de Rim / Vírus BK / Transplante de Células-Tronco Hematopoéticas / Infecções por Polyomavirus Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Tumorais por Vírus / Transplante de Rim / Vírus BK / Transplante de Células-Tronco Hematopoéticas / Infecções por Polyomavirus Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article